PHI with Periaxial encephalitis
How does this condition affect your private health insurance?
Encephalitis periaxialis, also known as Schilder's disease, is a rare, severe demyelinating disorder primarily affecting the central nervous system. It involves the extensive destruction of myelin, the protective sheath around nerve fibers, typically forming large, asymmetrical lesions in the cerebral hemispheres. Clinically, it manifests with progressive neurological deficits, including motor weakness, spasticity, visual and hearing impairment, seizures, and significant cognitive decline. The exact etiology remains largely unknown; it's often considered a variant of multiple sclerosis or a distinct leukodystrophy. Diagnosis relies heavily on characteristic MRI findings and exclusion of other demyelinating conditions. The disease is typically progressive and can be fatal.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months, often with rapid progression of symptoms.
Duration of Illness (Lifetime)
Chronic and relentlessly progressive, often leading to severe disability and premature death within months to several years.
Cost of Treatment (Initial)
High (e.g., tens of thousands to hundreds of thousands of USD) due to acute hospitalization, extensive diagnostic imaging, and initial immunosuppressive therapies.
Cost of Treatment (Lifetime)
Very high (e.g., hundreds of thousands to millions of USD) due to long-term neurological care, rehabilitation, medications, and potential chronic institutionalization.
Mortality Rate
High (e.g., 50-80% within 2-5 years, though highly variable depending on age of onset and specific subtype).
Risk of Secondary Damages
Very high (e.g., nearly 100%), encompassing severe motor deficits, visual/hearing loss, profound cognitive impairment, seizures, and eventually a vegetative state.
Probability of Full Recovery
Extremely low (e.g., <5%), as the disease is typically progressive and causes irreversible neurological damage.
Underlying Disease Risk
Very low. Schilder's disease is a primary demyelinating disorder and is not commonly a direct complication of other underlying diseases; rather, it is a distinct, rare condition.